Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bishwanath Pal

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Eye (London, England)|January 26, 2020
Ten-year outcomes of antivascular endothelial growth factor therapy in neovascular age-related macular degenerationShruti Chandra, Cristina Arpa, Deepthy Menon, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|January 13, 2010
Genotype-phenotype correlation for leber congenital amaurosis in Northern PakistanMartin McKibbin, Manir Ali, Moin D Mohamed, et al.
Ophthalmology and Therapy|June 20, 2020
Individualizing Therapy for Neovascular Age-Related Macular Degeneration with Aflibercept (VITAL): A Two-Year Prospective, Interventional Single-Centre TrialPraveen J Patel, Hari Jayaram, Maria Eleftheriadou, et al.
Ophthalmology. Retina|July 31, 2024
Real-World 1-Year Outcomes of Treatment-Intensive Neovascular Age-Related Macular Degeneration Switched to FaricimabSing Yue Sim, Evangelia Chalkiadaki, Georgios Koutsocheras, et al.
Ophthalmology and Therapy|February 27, 2025
The Impact of Disease Activity Criteria on Extending Injection Intervals in Real-World Patients with Neovascular Age-Related Macular DegenerationBhairavi Bhatia, Sing Yue Sim, Evangelia Chalkiadaki, et al.
The British Journal of Ophthalmology|December 17, 2011
Unilateral vitelliform maculopathy: a comprehensive phenotype study with molecular screening of BEST1 and PRPH2Mala Subash, Tryfonas Rotsos, Genevieve A Wright, et al.
Diabetes & Vascular Disease Research|January 30, 2016
Promoter polymorphism at the tumour necrosis factor/lymphotoxin-alpha locus is associated with type of diabetes but not with susceptibility to sight-threatening diabetic retinopathyGeorgia Kaidonis, Jamie E Craig, Mark C Gillies, et al.
Clinical & Experimental Ophthalmology|October 12, 2013
Genetic study of diabetic retinopathy: recruitment methodology and analysis of baseline characteristicsGeorgia Kaidonis, Sotoodeh Abhary, Mark Daniell, et al.
Acta Ophthalmologica|January 1, 2019
Unilateral pigmentary retinopathy: a retrospective case seriesMarie-Hélène Errera, Anthony G Robson, Tracey Wong, et al.
Molecular Vision|November 7, 2013
A new recessively inherited disorder composed of foveal hypoplasia, optic nerve decussation defects and anterior segment dysgenesis maps to chromosome 16q23.3-24.1Musallam Al-Araimi, Bishwanath Pal, James A Poulter, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Eye (London, England)|January 26, 2020
Ten-year outcomes of antivascular endothelial growth factor therapy in neovascular age-related macular degenerationShruti Chandra, Cristina Arpa, Deepthy Menon, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|January 13, 2010
Genotype-phenotype correlation for leber congenital amaurosis in Northern PakistanMartin McKibbin, Manir Ali, Moin D Mohamed, et al.
Ophthalmology and Therapy|June 20, 2020
Individualizing Therapy for Neovascular Age-Related Macular Degeneration with Aflibercept (VITAL): A Two-Year Prospective, Interventional Single-Centre TrialPraveen J Patel, Hari Jayaram, Maria Eleftheriadou, et al.
Ophthalmology. Retina|July 31, 2024
Real-World 1-Year Outcomes of Treatment-Intensive Neovascular Age-Related Macular Degeneration Switched to FaricimabSing Yue Sim, Evangelia Chalkiadaki, Georgios Koutsocheras, et al.
Ophthalmology and Therapy|February 27, 2025
The Impact of Disease Activity Criteria on Extending Injection Intervals in Real-World Patients with Neovascular Age-Related Macular DegenerationBhairavi Bhatia, Sing Yue Sim, Evangelia Chalkiadaki, et al.
The British Journal of Ophthalmology|December 17, 2011
Unilateral vitelliform maculopathy: a comprehensive phenotype study with molecular screening of BEST1 and PRPH2Mala Subash, Tryfonas Rotsos, Genevieve A Wright, et al.
Diabetes & Vascular Disease Research|January 30, 2016
Promoter polymorphism at the tumour necrosis factor/lymphotoxin-alpha locus is associated with type of diabetes but not with susceptibility to sight-threatening diabetic retinopathyGeorgia Kaidonis, Jamie E Craig, Mark C Gillies, et al.
Clinical & Experimental Ophthalmology|October 12, 2013
Genetic study of diabetic retinopathy: recruitment methodology and analysis of baseline characteristicsGeorgia Kaidonis, Sotoodeh Abhary, Mark Daniell, et al.
Acta Ophthalmologica|January 1, 2019
Unilateral pigmentary retinopathy: a retrospective case seriesMarie-Hélène Errera, Anthony G Robson, Tracey Wong, et al.
Molecular Vision|November 7, 2013
A new recessively inherited disorder composed of foveal hypoplasia, optic nerve decussation defects and anterior segment dysgenesis maps to chromosome 16q23.3-24.1Musallam Al-Araimi, Bishwanath Pal, James A Poulter, et al.
Pageof 3